I received my M.Sc. and Ph.D. at Warwick University, UK, studying an alphavirus, and was a post-doc in Virology at Helsinki University. I returned to Warwick University, working on interferon, before joining a start-up, Codon, in the Bay Area to work on coagulation and fibrinolysis. The start-up was acquired by Schering (Berlex), where I was Scientific Director for Cardiovascular before transferring to Kobe, Japan as Head of Regenerative Medicine with a CNS focus. I was then a JPS scholar in Immunology at Mie University, before joining Hematology at Stanford University.